Beth Faiman, PhD, APRN-BC, AOCN

Authored Items

Staying Abreast of New Treatments

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Survivorship Care and Multiple Myeloma

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

How Janssen CarePath Helps Patients

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Concerns Over New Multiple Myeloma Therapies

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Self-Managing Side Effects

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

The Challenge of Managing Treatment-Related Toxicites

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Unmet Needs in Patients with Myeloma

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

What Do Patients Ask About Daratumumab?

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Starting a Patient on Daratumumab

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Perceptions of Daratumumab Therapy

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Managing Patients with Multiple Myeloma

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH

Improving the Management of Patients on Oral Regimens

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Conference Correspondent, ASH

Utilizing Patient Support Services

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Conference Correspondent, ASH

The Impact of New Multiple Myeloma Treatments

Beth Faiman, PhD, APRN-BC, AOCN

Conference Correspondent  in Conference Correspondent, ASH

Impact of the Affordable Care Act on Cancer Care: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Conquering the Cancer Care Continuum - Series Three: Fourth Issue in Supplements

Side Effect Management: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Conquering the Cancer Care Continuum - Series Three: Third Issue in Supplements

Access to Quality Care: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Conquering the Cancer Care Continuum - Series Three: Second Issue in Supplements

Good Manufacturing Practice: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Conquering the Cancer Care Continuum - Series Three: First Issue in Supplements

The Role of Biosimilars in Oncology: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Sixth Issue 2013 series: Conquering the Cancer Care Continuum

The Importance of Cancer Survivorship Care Plans: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Fifth Issue 2013 series: Conquering the Cancer Care Continuum in Supplements

Personalized Treatment Planning: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Fourth Issue 2013 series: Conquering the Cancer Care Continuum

Hospice Care Options: A Nurse’s Perspective

Beth Faiman, PhD, APRN-BC, AOCN

Third Issue 2013 series: Conquering the Cancer Care Continuum

Classifying and Managing Pain in the Oncology Patient

Beth Faiman, PhD, APRN-BC, AOCN

Second Issue 2013 series: Conquering the Cancer Care Continuum

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Carfilzomib: A New Agent in the Treatment Armamentarium for Multiple Myeloma

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Carfilzomib: A New Agent in the Treatment Armamentarium for Multiple Myeloma

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Next-Generation Proteasome Inhibition in Multiple Myeloma

Kim Redic, PharmD, BCPS, Beth Faiman, PhD, APRN-BC, AOCN

TOP - Supplements

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives

Stakeholder’s Perspective: Nursing

Beth Faiman, PhD, APRN-BC, AOCN

Web Exclusives